25
JAN
2016
NW Bio Presenting At Phacilitate Immunotherapy World Forum
Comments : Off
BETHESDA, MD, January 25, 2016 – Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for operable and inoperable solid tumor cancers, announced today that CEO Linda Powers will chair the morning plenary session and present at the Phacilitate Immunotherapy World Forum on Tuesday, January 26, 2016, at the Grand Hyatt Hotel in Washington DC. The plenary... Read More